An observational analysis has found that the drugs may lower the risk of substance abuse and cognitive issues. But the ...

With GLP-1-related drugs having won the race to weight loss approval, attention at many obesity-focused biopharmas has turned ...

An investigational drug from Veru helped preserve lean mass in patients taking Wegovy, though some experts raised questions ...

One of Novo Nordisk's next-generation obesity shots to follow up on the success of Wegovy helped patients lose 22% of their ...

Ro details dietary choices that may help Wegovy's capacity to regulate appetite and foster a healthier weight as well as ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

Ozempic and Wegovy are among the 15 additional drugs selected for a list that will be negotiated for lower Medicare prices. Ten other drugs have already been selected for the Medicare list in an ...

WASHINGTON (AP) — Popular weight loss and diabetes drugs like Ozempic and Wegovy have been added to ... about $6 billion for taxpayers and $1.5 billion for Medicare enrollees.

The US plans to slash the price it pays for the Novo Nordisk A/S blockbusters Ozempic and Wegovy, the latest drugs to be targeted under legislation that’s expected save the government more than ...

Dec. 14, 2023. (AP Photo/Andrew Harnik, File) The injectable drug Ozempic is shown, July 1, 2023, in Houston. (AP Photo/David J. Phillip, File) A dosage of Wegovy, March 1, 2024 in Front Royal, Va.

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will be subject to the next round of Medicare price negotiations ...

WASHINGTON (AP) — Popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug ...